Sylvain Fisson Genethon Biography Publications Institution JoVE Articles Sylvain Fisson has not added a biography. If you are Sylvain Fisson and would like to personalize this page please email our Author Liaison for assistance. Publications ISOLD: A New Highly Sensitive Interleukin Score for Intraocular Lymphoma Diagnosis Ophthalmology. Jul, 2016 | Pubmed ID: 26948307 Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T Cells Journal of Immunology (Baltimore, Md. : 1950). Mar, 2016 | Pubmed ID: 26826251 Mouse Models of Primary Central Nervous System Lymphomas: Tools for Basing Funding and Therapeutic Strategies Journal of Neuro-oncology. Jan, 2015 | Pubmed ID: 25300908 Immunization of Mice with Lentiviral Vectors Targeted to MHC Class II+ Cells is Due to Preferential Transduction of Dendritic Cells in Vivo PloS One. 2014 | Pubmed ID: 25058148 Herpesvirus Detection and Cytokine Levels (IL-10, IL-6, and IFN-γ) in Ocular Fluid from Tunisian Immunocompetent Patients with Uveitis Journal of Medical Virology. Dec, 2013 | Pubmed ID: 23960020 Preclinical Study of Ublituximab, a Glycoengineered Anti-human CD20 Antibody, in Murine Models of Primary Cerebral and Intraocular B-cell Lymphomas Investigative Ophthalmology & Visual Science. May, 2013 | Pubmed ID: 23611989 Lymphoma B-cell Responsiveness to CpG-DNA Depends on the Tumor Microenvironment Journal of Experimental & Clinical Cancer Research : CR. 2013 | Pubmed ID: 23561041 Cytokine Profile in Human Eyes: Contribution of a New Cytokine Combination for Differential Diagnosis Between Intraocular Lymphoma or Uveitis PloS One. 2013 | Pubmed ID: 23405064 Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models Frontiers in Immunology. 2012 | Pubmed ID: 22566974 Murine Models of B-cell Lymphomas: Promising Tools for Designing Cancer Therapies Advances in Hematology. 2012 | Pubmed ID: 22400032 Th17 Cells Are Involved in the Local Control of Tumor Progression in Primary Intraocular Lymphoma PloS One. 2011 | Pubmed ID: 21949734 The Immune Microenvironments of Lung and Intraocular Tumors Bulletin Du Cancer. Jun, 2011 | Pubmed ID: 21616749 Tumor Microenvironment is Multifaceted Cancer Metastasis Reviews. Mar, 2011 | Pubmed ID: 21271351 Immune Infiltration in Human Cancer: Prognostic Significance and Disease Control Current Topics in Microbiology and Immunology. 2011 | Pubmed ID: 20512556 The Future of Primary Intraocular Lymphoma (retinal Lymphoma) Ocular Immunology and Inflammation. Nov-Dec, 2009 | Pubmed ID: 20001255 Selective Expression of Inhibitory Fcgamma Receptor by Metastatic Melanoma Impairs Tumor Susceptibility to IgG-dependent Cellular Response International Journal of Cancer. Dec, 2008 | Pubmed ID: 18798552 Animal Models of Intraocular Lymphomas Ophthalmic Research. 2008 | Pubmed ID: 18421241 Expansion of CD4+CD25+ Regulatory T Cells by Intravenous Immunoglobulin: a Critical Factor in Controlling Experimental Autoimmune Encephalomyelitis Blood. Jan, 2008 | Pubmed ID: 17932250 Impaired Th1/tc1 Cytokine Production of Tumor-infiltrating Lymphocytes in a Model of Primary Intraocular B-cell Lymphoma Investigative Ophthalmology & Visual Science. Jul, 2007 | Pubmed ID: 17591892 Induction of Antigen-specific Tolerance by Intrathymic Injection of Lentiviral Vectors Blood. Nov, 2006 | Pubmed ID: 16809618 Regulatory T Cells Control Uveoretinitis Induced by Pathogenic Th1 Cells Reacting to a Specific Retinal Neoantigen Journal of Immunology (Baltimore, Md. : 1950). Jun, 2006 | Pubmed ID: 16751360 Therapeutic Potential of Self-antigen-specific CD4+ CD25+ Regulatory T Cells Selected in Vitro from a Polyclonal Repertoire European Journal of Immunology. Apr, 2006 | Pubmed ID: 16525991 Natural Regulatory T Cells Control the Development of Atherosclerosis in Mice Nature Medicine. Feb, 2006 | Pubmed ID: 16462800 Identification of New CNS-resident Macrophage Subpopulation Molecular Markers for the Discrimination with Murine Systemic Macrophages Journal of Neuroimmunology. Dec, 2005 | Pubmed ID: 16169092 Ex Vivo Selection of Recipient-type Alloantigen-specific CD4(+)CD25(+) Immunoregulatory T Cells for the Control of Graft-versus-host Disease After Allogeneic Hematopoietic Stem-cell Transplantation Transplantation. Jan, 2004 | Pubmed ID: 14726768 Recipient-type Specific CD4+CD25+ Regulatory T Cells Favor Immune Reconstitution and Control Graft-versus-host Disease While Maintaining Graft-versus-leukemia The Journal of Clinical Investigation. Dec, 2003 | Pubmed ID: 14660744 Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State The Journal of Experimental Medicine. Sep, 2003 | Pubmed ID: 12939344 Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models Jeremie Cosette1,2,3, Rym Ben Abdelwahed2, Sabrina Donnou-Triffault1,4,5, Catherine Sautès-Fridman2, Patrice Flaud*3, Sylvain Fisson*1,4,5 1Genethon, 2Cordeliers Research Center, INSERM U872, 3Matter and Complex Systems Laboratory, Université Paris Diderot, 4INSERM U951, 5UMR_S951, Université d'Evry Val d'Essonne JoVE 53609 Médecine
Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models Jeremie Cosette1,2,3, Rym Ben Abdelwahed2, Sabrina Donnou-Triffault1,4,5, Catherine Sautès-Fridman2, Patrice Flaud*3, Sylvain Fisson*1,4,5 1Genethon, 2Cordeliers Research Center, INSERM U872, 3Matter and Complex Systems Laboratory, Université Paris Diderot, 4INSERM U951, 5UMR_S951, Université d'Evry Val d'Essonne JoVE 53609 Médecine